NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

sharpie510 Tuesday, 08/25/20 03:49:24 PM

Post # 302089
I wrote to Sichen Li, one of the sponsor contacts, early this year. I asked her if ATL-DC was DCVax-L but just a generic name for it.

I asked:
Quote:
Is this trial using DCVax-L as part of the protocol? What is ATL-DC? Is that just the generic term for DCVax-L? Thanks again.
She replied:
Quote:
Yes to all your questions.
I'm satisfied that if this trial shows ATL-DC is efficacious in rGBM (either as a monotherapy or in combination with pembrolizumab), DCVax-L will be the beneficiary. Also note that this trial also uses the generic name pembrolizumab instead of Keytruda.

I think Senti also asked a UCLA rep at some gathering in SoCal a few months ago and essentially got the same answer